YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma

J. H. Lee, K. H. Park, Jungwon Park, C. S. Hong

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Serum chitinase-like proteins such as YKL-40 in asthmatic patients are known to positively correlate with disease severity but controversy remains regarding their role. The allergen bronchial provocation test (ABPT) can induce allergic airway inflammation in individuals with atopic asthma. Objective: To evaluate the induction and kinetics of YKL-40 during allergen-induced airway inflammation in atopic asthmatics. Methods: Thirteen patients were enrolled from May to November 2008. They all underwent ABPT with Dermatophagoides farinae crude extract. Induced sputums (IS) and serum were collected 3 times: 7 days before ABPT (baseline), 7 hours after ABPT, and 24 hours after ABPT. We examined the cytology of induced sputum (IS) and measured levels of YKL-40, interleukin (IL) 4, IL-5, IL-13, IL-33, tumor necrosis factor (TNF) a, and eosinophilic cationic protein (ECP) in IS and/or serum. Results: Following ABPT, total inflammatory cells, eosinophils, and neutrophils increased in a time-dependent manner in IS. YKL-40 levels were increased in IS but not in serum at 7 or 24 hours after ABPT (P=.011 and P=.006, respectively). Similarly to YKL-40, IL-5 and ECP levels were also increased in IS at 7 and 24 hours after ABPT (P=.011 for IL-5 and P=.006 for ECP). Overall, YKL-40 levels were well correlated with ECP levels in IS (p=0.576, P<.001). Conclusions: YKL-40 levels increased immediately in IS but not in the serum of atopic asthmatics. The correlation between YKL-40 levels and ECP in IS suggests that YKL-40 may play a pathophysiologic role in human atopic asthma.

Original languageEnglish
Pages (from-to)501-507
Number of pages7
JournalJournal of Investigational Allergology and Clinical Immunology
Volume22
Issue number7
Publication statusPublished - 2012 Dec 24

Fingerprint

Bronchial Provocation Tests
Sputum
Allergens
Asthma
Interleukin-5
Serum
Proteins
Dermatophagoides farinae
Inflammation
Chitinases
Interleukin-13
Complex Mixtures
Eosinophils
Interleukin-4
Cell Biology
Neutrophils
Tumor Necrosis Factor-alpha

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

@article{ea5aa97a7ce84162b9fdf92f5fa522c5,
title = "YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma",
abstract = "Background: Serum chitinase-like proteins such as YKL-40 in asthmatic patients are known to positively correlate with disease severity but controversy remains regarding their role. The allergen bronchial provocation test (ABPT) can induce allergic airway inflammation in individuals with atopic asthma. Objective: To evaluate the induction and kinetics of YKL-40 during allergen-induced airway inflammation in atopic asthmatics. Methods: Thirteen patients were enrolled from May to November 2008. They all underwent ABPT with Dermatophagoides farinae crude extract. Induced sputums (IS) and serum were collected 3 times: 7 days before ABPT (baseline), 7 hours after ABPT, and 24 hours after ABPT. We examined the cytology of induced sputum (IS) and measured levels of YKL-40, interleukin (IL) 4, IL-5, IL-13, IL-33, tumor necrosis factor (TNF) a, and eosinophilic cationic protein (ECP) in IS and/or serum. Results: Following ABPT, total inflammatory cells, eosinophils, and neutrophils increased in a time-dependent manner in IS. YKL-40 levels were increased in IS but not in serum at 7 or 24 hours after ABPT (P=.011 and P=.006, respectively). Similarly to YKL-40, IL-5 and ECP levels were also increased in IS at 7 and 24 hours after ABPT (P=.011 for IL-5 and P=.006 for ECP). Overall, YKL-40 levels were well correlated with ECP levels in IS (p=0.576, P<.001). Conclusions: YKL-40 levels increased immediately in IS but not in the serum of atopic asthmatics. The correlation between YKL-40 levels and ECP in IS suggests that YKL-40 may play a pathophysiologic role in human atopic asthma.",
author = "Lee, {J. H.} and Park, {K. H.} and Jungwon Park and Hong, {C. S.}",
year = "2012",
month = "12",
day = "24",
language = "English",
volume = "22",
pages = "501--507",
journal = "Journal of Investigational Allergology and Clinical Immunology",
issn = "1018-9068",
publisher = "Esmon",
number = "7",

}

YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma. / Lee, J. H.; Park, K. H.; Park, Jungwon; Hong, C. S.

In: Journal of Investigational Allergology and Clinical Immunology, Vol. 22, No. 7, 24.12.2012, p. 501-507.

Research output: Contribution to journalArticle

TY - JOUR

T1 - YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma

AU - Lee, J. H.

AU - Park, K. H.

AU - Park, Jungwon

AU - Hong, C. S.

PY - 2012/12/24

Y1 - 2012/12/24

N2 - Background: Serum chitinase-like proteins such as YKL-40 in asthmatic patients are known to positively correlate with disease severity but controversy remains regarding their role. The allergen bronchial provocation test (ABPT) can induce allergic airway inflammation in individuals with atopic asthma. Objective: To evaluate the induction and kinetics of YKL-40 during allergen-induced airway inflammation in atopic asthmatics. Methods: Thirteen patients were enrolled from May to November 2008. They all underwent ABPT with Dermatophagoides farinae crude extract. Induced sputums (IS) and serum were collected 3 times: 7 days before ABPT (baseline), 7 hours after ABPT, and 24 hours after ABPT. We examined the cytology of induced sputum (IS) and measured levels of YKL-40, interleukin (IL) 4, IL-5, IL-13, IL-33, tumor necrosis factor (TNF) a, and eosinophilic cationic protein (ECP) in IS and/or serum. Results: Following ABPT, total inflammatory cells, eosinophils, and neutrophils increased in a time-dependent manner in IS. YKL-40 levels were increased in IS but not in serum at 7 or 24 hours after ABPT (P=.011 and P=.006, respectively). Similarly to YKL-40, IL-5 and ECP levels were also increased in IS at 7 and 24 hours after ABPT (P=.011 for IL-5 and P=.006 for ECP). Overall, YKL-40 levels were well correlated with ECP levels in IS (p=0.576, P<.001). Conclusions: YKL-40 levels increased immediately in IS but not in the serum of atopic asthmatics. The correlation between YKL-40 levels and ECP in IS suggests that YKL-40 may play a pathophysiologic role in human atopic asthma.

AB - Background: Serum chitinase-like proteins such as YKL-40 in asthmatic patients are known to positively correlate with disease severity but controversy remains regarding their role. The allergen bronchial provocation test (ABPT) can induce allergic airway inflammation in individuals with atopic asthma. Objective: To evaluate the induction and kinetics of YKL-40 during allergen-induced airway inflammation in atopic asthmatics. Methods: Thirteen patients were enrolled from May to November 2008. They all underwent ABPT with Dermatophagoides farinae crude extract. Induced sputums (IS) and serum were collected 3 times: 7 days before ABPT (baseline), 7 hours after ABPT, and 24 hours after ABPT. We examined the cytology of induced sputum (IS) and measured levels of YKL-40, interleukin (IL) 4, IL-5, IL-13, IL-33, tumor necrosis factor (TNF) a, and eosinophilic cationic protein (ECP) in IS and/or serum. Results: Following ABPT, total inflammatory cells, eosinophils, and neutrophils increased in a time-dependent manner in IS. YKL-40 levels were increased in IS but not in serum at 7 or 24 hours after ABPT (P=.011 and P=.006, respectively). Similarly to YKL-40, IL-5 and ECP levels were also increased in IS at 7 and 24 hours after ABPT (P=.011 for IL-5 and P=.006 for ECP). Overall, YKL-40 levels were well correlated with ECP levels in IS (p=0.576, P<.001). Conclusions: YKL-40 levels increased immediately in IS but not in the serum of atopic asthmatics. The correlation between YKL-40 levels and ECP in IS suggests that YKL-40 may play a pathophysiologic role in human atopic asthma.

UR - http://www.scopus.com/inward/record.url?scp=84871309020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871309020&partnerID=8YFLogxK

M3 - Article

C2 - 23397672

AN - SCOPUS:84871309020

VL - 22

SP - 501

EP - 507

JO - Journal of Investigational Allergology and Clinical Immunology

JF - Journal of Investigational Allergology and Clinical Immunology

SN - 1018-9068

IS - 7

ER -